Maudsley Forum Scandinavia,
an intensive state-of-the-art educational conference

About Maudsley Forum Scandinavia

The University Psychiatric Department of Helsingborg in collaboration with King’s College London and the Lund University Department of Child and Adolescent Psychiatry proudly present

Maudsley Forum Scandinavia
- an intensive, three-day state-of-the-art educational conference.


World-class speakers, leading experts from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and distinguished Scandinavian clinicians and researchers, with a worldwide reputation for psychiatric research and clinical care, will meet in Helsingborg and present cutting edge advances in clinical and academic psychiatry. The Forum will provide a top-level update on social, psychological and biological aspects of psychiatric disorders, reviewing advances in diagnostics and new methods of treatment.

It consists of a broad spectrum of lectures, in the fields of Adult Psychiatry, Forensic Psychiatry and Child and Adolescent Psychiatry, addressing topics such as psychotic and mood disorders, addiction, pharmacological and psychological treatment interventions, genetics and epigenetics in psychiatry, neuroimaging and neurocognition.

The meeting will be held in Helsingborg, at Elite Hotel Marina Plaza, 20th to the 22nd April 2020.

Please note that the lectures will be in English.


The establishment of this first Maudsley Forum Scandinavia is orchestrated by Professor Sir Robin Murray, Professor Allan Young and Associate Professor Jonas Eberhard, from the Institute of Psychiatry, Psychology & Neuroscience, King's College London and Lund University, Sweden.

Our intention is that this conference will become an annual, long-lasting tradition, introducing a Forum for networking, exchange of ideas and cooperation. The conference is primarily intended for psychiatrists - specialists and residents, but also for clinical psychologists, mental health professionals as well as neuroscientists and students.  

REGISTRATION
The registration is open until April 12th 2020 but we offer a limited number of places for this exclusive event so feel free to register as soon as possible. 

Fees 
- Registrations before February 1st: 5900 SEK. 
- Registrations between February 1st and 20th of March: 6900 SEK
- Registrations after the 20th of March until the 12th of April: 7900 SEK.

Lipus has reviewed and approved this course. The complete course description is available at www.lipus.se (Lipus-no: 20200015).

PROGRAMME
Download preliminary programme, subject to changes (pdf).

Organizational committee
- Jonas Eberhard, Associate Professor, Lund University
- Spyridon Baltzis, resident (ST-läkare) in Psychiatry, Helsingborg
- Maria Holst, head of the University Psychiatric Department of Helsingborg,
- Gisela Larmark, consultant psychiatrist, director of Clinical Education
- Charlotte Hedin, communications coordinator
- Camilla Christensson, administrative assistant
- Hans Nielsen Fex, financial officer

For further information, please contact:
Spyridon Baltzis, project leader
maudsley.forum.scandinavia@skane.se
+46 70 150 59 01

Event Schedule – MONDAY 20 APRIL

Preliminary programme, subject to changes.

Morning 20 April
  • 9:00 - 9:45 am - Registration and Introduction

    Registration opens 08:30        

    Introduction 9:15 - 9:45
    Associate Professor Jonas Eberhard, Professor Sir Robin Murray, Professor Allan Young and dr. Spyridon Baltzis

  • 9:45 - 10:30 am - The New Understanding of Schizophrenia and Bipolar Disorder

    Professor Sir Robin Murray  

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Child & Adolescent Psychiatry

    Professor Andrea Danese

  • 11:45 - 12:30 pm - Cognitive Impairment in Bipolar Disorders

    Professor Allan Young

Afternoon 20 April
  • 12:30- 1:30 pm - Lunch
  • 1:30 - 2:15 pm - The physical health of people with psychosis

    Dr. Fiona Gaughran

  • 2:15 - 2:45 pm - Fika Pause
  • 2:45 - 3:30 pm - Dementia

    Professor Dag Aarsland

  • 3:30 - 4:15 pm - Using inflammation to personalizing antidepressant therapy 

    Associate Professor Daniel Lindqvist

Event Schedule - TUESDAY 21 APRIL

Preliminary programme, subject to changes.

Morning 21 April
  • 9:00 - 9:45 am - If the Doors of Perception Were Cleansed... Is Schizophrenia a Disorder of Cellular Cleanliness?

    Professor and Executive Dean Ian Everall

  • 9:45 - 10:30 am - Psychopharmacological Treatment of Depression

    Professor Allan Young

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Factors leading to the onset of psychosis and the prevention of psychosis

    Professor Philip McGuire

  • 11:45 - 12:30 pm - Outcome of Psychosis is better than you think

    Professor Sir Robin Murray

Afternoon 21 April
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm - Alcohol interventions: what offers the best value?

    Professor Colin Drummond

  • 2:45 - 3:30 pm - Sex, Drugs and Rock & Roll - Sexual side effects of psychotropics

    Professor Steve Bazire

  • 3:30 - 4:15 pm - The use of smartphones for monitoring and treatment in bipolar disorder

    Professor Maria Faurholt-Jepsen

Evening 21 April
  • 6:30 - 11:00 pm - Dinner

Event Schedule - WEDNESDAY 22 APRIL

Preliminary programme, subject to changes.

Morning 22 April
  • 9:00 - 9:45 am - War Psychiatry

    Professor Sir Simon Wessely

  • 9:45 - 10:30 am - Obsessive-compulsive and related disorders: an update

    Professor David Mataix-Cols

  • 10:30 - 11:00 am - Fika Pause
  • 11:00 - 11:45 am - Neuroimaging of schizophrenia symptoms and implications for treatment

    Professor Sukhi Shergill

  • 11:45 - 12:30 pm - Opium overdose

    Professor Sir John Strang

Afternoon 22 April
  • 12:30 - 1:30 pm - Lunch
  • 1:30 - 2:15 pm - Gambling disorder - advances in public health and in clinical addiction treatment

    Professor Anders Håkansson

  • 2:15 - 2:45 pm - Fika Pause
  • 2:45 - 3:30 pm - Eating disorders in young adults: prevalence, diagnostics and treatment

    Professor Maria Råstam Bergström

  • 3:30 - 4:15 pm - Violence: neurobiology and management

    Dr. Shubulade Smith

  • 4:15 - 5:00 pm - Progress, Problems, Prospects and Expectations

    Associate Professor Jonas Eberhard and Dr. Spyridon Baltzis

Speakers of the Event

Dag Aarsland is Professor of Old Age Psychiatry at IoPPN, King’s College London. Visiting professor at the Alzheimer's Disease Research Centre at Karolinska Institutet, Sweden and Research Director at Centre for Age-Related Medicine, Stavanger University Hospital, Norway. A psychiatrist who has worked as a senior consultant in geriatric psychiatry for most of his career. Main research interest is the neuropsychiatric aspects of patients with neurodegenerative diseases, in particular translational studies on cognitive decline in Parkinson’s disease and dementia with Lewy bodies.
Dag Aarsland

Professor

Professor Allan Young holds the Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the IoPPN, King’s College London. Research focus on the cause and treatments for severe psychiatric illnesses, particularly mood disorders. He has received research grant funding from the UK Medical Research Council, the Stanley Medical Research Institute, the Canadian Institutes for Heath Research, the National Institutes of Health (USA) and numerous other agencies. He has published over 400 publications and a number of books.
Allan Young

Professor

Andrea Danese is Professor of Child and Adolescent Psychiatry at the Social, Genetic, and Developmental Psychiatry (SGDP) Centre, and the Department of Child and Adolescent Psychiatry, IoPPN, King’s College London. Consultant Child and Adolescent Psychiatrist at the National and Specialist CAMHS Trauma, Anxiety, and Depression Clinic at the Michael Rutter Centre, Maudsley Hospital, London, UK. Heads the Stress and Development Lab, and his team has published widely on the consequences of childhood trauma, the biological mechanisms through which childhood trauma affects health.
Andrea Danese

Professor

Colin Drummond, Professor of Addiction Psychiatry, Head of the Alcohol Research Group and Consultant Psychiatrist at the National Addiction Centre, IoPPN, King’s College London and South London and Maudsley NHS Foundation Trust. Principal investigator on research grants from the Department of Health, National Institute for Health Research and the European Commission, including the DH funded national alcohol needs assessment project and a national research programme on alcohol screening and brief intervention. Member of the WHO Expert Committee on Drug Dependence and Alcohol Problems and of the Public Health England Alcohol Leadership Board.
Colin Drummond

Professor

Philip McGuire, Head of Department of Psychosis Studies at the IoPPN, Academic Director and joint Leader of the Psychosis Clinical Academic Group, King’s Health Partners. Fellow of the Academy of Medical Sciences, the Royal College of Psychiatrists, the European Psychiatric Association, and the International College of Neuropsychopharmacology. Studied physiology and medicine at the University of Edinburgh, worked as a research fellow in neuroscience at Yale University and trained psychiatry at the Maudsley Hospital. Leads clinical academic research group focused on understanding the mechanisms underlying psychosis and developing treatments.
Philip McGuire

Professor

Fiona Gaughran, Director of Research and Development at the South London and Maudsley NHS Foundation Trust in London, Lead Consultant for the National Psychosis Service. Reader in Psychopharmacology and Physical Health at the Institute of Psychiatry, Psychology and Neuroscience. Fellow of the Royal Colleges of Physicians in London, Edinburgh and Dublin and of the Royal College of Psychiatrists. Implementing new, evidence-based approaches to help people who have psychotic illnesses that have been resistant to treatment. Research interests focus on the interface between physical health and severe mental illness and on the management of psychosis.
Professor Maria Faurholt-Jepsen has extensive experiences in conducting clinical research and is internationally one of the few leading researchers within the field of smartphone based monitoring, diagnosing and treatment in patients with bipolar disorder. Maria is internationally one of the few in front and was the first to investigate smartphone-based monitoring as a marker and treatment in patients with bipolar disorder. The findings from her research are innovative and point toward the use of smartphone-based monitoring as a marker of illness in bipolar disorder. Using smartphones as a treatment has a potential global reach, filling the gap between availability and the need for treatment.

For further information
Sir Robin Murray, Professor of Psychiatric Research at the IoPPN. Particular interest is in psychosis and has contributed to the understanding that environmental factors dysregulate striatal dopamine and thus increase the risk of schizophrenia-like psychoses. He is also involved in testing new treatments for psychotic illnesses, and cares for people with psychosis at the SLaM NHS Foundation Trust. Written over 700 articles. Most frequently cited schizophrenia researcher outside the USA. Has supervised 52 PhDs and 40 of his students have become full professors. Elected a Fellow of the Royal Society in 2010 and received a knighthood in 2011.
Sir Robin Murray

Professor

Sukhi Shergill, Professor of Psychiatry and Systems Neuroscience at the Institute of Psychiatry, Psychology and Neuroscience, King's College London. Consultant Psychiatrist at the Maudsley Hospital. His research aims to understand more about the brain mechanisms involved in the symptoms of psychosis in order to develop effective treatments. Professor Shergill is director of the King’s centre for central nervous system therapeutics which facilitates collaboration to develop novel therapeutic approaches applied to mental health and neurology, between industry, academics and the clinicians within the Institute of Psychiatry, Psychology and Neuroscience, King's College London, and the Maudsley Hospital.
Sukhi Shergill

Professor

Sir John Strang, Director of the National Addiction Centre, Head of the Addictions Department at King’s College London. Leads the new theme investigating ‘Lifestyle Substance Use & Harms’ as part of the new Biomedical Research Centre in Mental Health. Selected as an NIHR Senior Investigator. Co-Leads the Addictions Clinical Academic Group of Kings Health Partners AHSC. Addictions psychiatrist for over 30 years and has led the group at the Maudsley/Institute since 1995. Has contributed to national and international policy, chairing policy-informing committees and expert groups for Department of Health, NICE and Public Health England.
Sir John Strang

Professor

Sir Simon Wessely is a Professor of Psychological Medicine and Regius Professor of Psychiatry at King’s College London and a Consultant Liaison Psychiatrist at King’s College and the Maudsley Hospitals. His doctorate is in epidemiology, and he has over 700 original publications, with an emphasis on the boundaries of medicine and psychiatry, unexplained symptoms and syndromes, population reactions to adversity, military health, epidemiology and others.  He has co-authored books on chronic fatigue syndrome, randomised controlled trials and a history of military psychiatry. Professor Wessely is also President of the Royal Society of Medicine.
Sir Simon Wessely

Professor

Daniel Lindqvist, associate professor at Lund University and psychiatry resident in Lund, Skåne. Completed his PhD in 2010 and did his postdoc in Owen Wolkowitz research group at University of California, San Francisco. Dr Lindqvist is currently running three antidepressant treatment studies and is supervising several doctoral students and postdocs. He´s dedicated to understanding the neurobiological underpinnings of depression and anxiety disorders, conditions for which current treatments in many cases are unsatisfactory. Therefore, it is of importance to gain a better understanding of the neurobiological underpinnings of these disorders and to develop new biological treatment targets.
Daniel Lindqvist

Associate Professor

Stephen Bazire; Honorary Professor at the School of Pharmacy, University of East Anglia in Norwich, a Director of Mistura Enterprise and Mistura Informatics and a Trustee for Norfolk and Waveney Mind. Chief Pharmacist for Norfolk mental health services 1986-2011 and Consultant Pharmacist in Medicines Management until retiring from the NHS in 2015. Fellow of the Royal Pharmaceutical Society of Great Britain and the College of Mental Health Pharmacy, was awarded an MBE in 2010 for services to pharmacy and the Guild of Healthcare Pharmacists Gold Medal in 2013. Author of the "Psychotropic Drug Directory". Clinical interests: depression, bipolar, adult ADHD, and user and carer information and education on medicines.
Stephen Bazire

Professor

Jonas Eberhard, Reader at Lund University, and Honorary faculty at the Institute of Psychiatry at the Maudsley. Involved in Psychiatric drug development since the early 90ies most recently as Lundbeck HQ global medical adviser. Currently program responsible scientific secretary of the Swedish Psychiatric Association, editor for the Nordic Journal of Psychiatry and ‘Digital Psychiatry’. Author of numerous scientific articles and editor of several books in the areas of psychosis, cognition, and psychiatric-physical co-morbidity. Basic training at the Ludwig Maximilian University in Munich and Karolinska Institute; Clinical training and dissertation at Lund University, and post-doc at KCL.
 
Jonas Eberhard

Associate Professor

Dr Shubulade Smith is a Visiting Senior Lecturer in the Department of Forensic and Neurodevelopmental Sciences at the IoPPN and a Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust. She is known for her work in the hormonal and reproductive effects of antipsychotic medications. She is a Module Co-Lead for the MSc in Clinical Neurodevelopmental Science and also teaches regularly on the Maudsley MRCPsych training course. She also works at the Royal College of Psychiatrists where she´s the Clinical Director for the National Collaborating Centre for Mental Health. More recently she was a key contributor to the Independent Mental Health Act Review, chaired by Professor Sir Simon Wessely.
Maria Råstam is senior professor at Lund University and at the University of Gothenburg.
 
She went to Medical School at the University of Gothenburg. She has specialised in General psychiatry and in Child and adolescent psychiatry. In 2008 she was appointed Full professor in Child and adolescent psychiatry at Lund University, associated with a post as senior consultant psychiatrist. Since 2016 she is senior professor at the same university.

Her research areas are the eating disorders and the neurodevelopmental disorders, esp. autism and ADHD. She has published over 140 peer-reviewed papers in international journals.
Maria Råstam Bergström

Professor

Anders Håkansson is a professor of addiction medicine at Lund University, and a consultant physician at the gambling disorder unit and at the outpatient facilities for sports psychiatry at Malmö Addiction Center, Sweden. A large part of Anders Håkansson's research focuses on gambling disorder, its comorbidity, psychiatric, social and societal consequences, and on prevention and harm reduction interventions in problem gambling. Likewise, Anders is the responsible researcher of the regional naloxone trial in Region Skåne, aiming to decrease opioid overdose-related mortality in the society, as well as for a number of other research projects in alcohol and drug use disorder, problem gambling and gaming, as well as in other non-substance behavioral addictions. Anders Håkansson is a professor of addiction medicine at Lund University, and a consultant physician at the gambling disorder unit and at the outpatient facilities for sports psychiatry at Malmö Addiction Center, Sweden. A large part of Anders Håkansson's research focuses on gambling disorder, its comorbidity, psychiatric, social and societal consequences, and on prevention and harm reduction interventions in problem gambling. Likewise, Anders is the responsible researcher of the regional naloxone trial in Region Skåne, aiming to decrease opioid overdose-related mortality in the society, as well as for a number of other research projects in alcohol and drug use disorder, problem gambling and gaming, as well as in other non-substance behavioral addictions. 
Anders Håkansson

Professor

Spyridon Baltzis

Dr.

The complete course description is available at www.lipus.se (Lipus-no: 20200015).

Lipus - läkarnas institut för professionell utveckling i sjukvården. Lipus är ledande i Sverige inom extern granskning av AT- och ST-utbildningar samt certifiering av kurser för läkare.

About Lipus - in English
Lipus has reviewed and approved this course.

Partners/Sponsors

Venue

Elite Hotel Marina Plaza Helsingborg, Sweden

Event Location

Get Directions

Enjoy your stay in Helsingborg

- Attractions and activities
- Eat and drink
- Guides
- Shopping
- Good to know

Where to stay
- Accommodation  
- Hotel Map

How to get to, and get around in, Helsingborg
- Helsingborg Convention & Event Bureau
- Visit Helsingborg map

Public transport
- skanetrafiken.se

Let's Get Social

Region Skåne Koncernkontoret © . All Rights Reserved.
Landing Page Template Designed & Developed By: Saptarang